West Pharmaceutical Services (NYSE:WST) Downgraded by StockNews.com
StockNews.com lowered shares of West Pharmaceutical Services (NYSE:WST – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday. WST has been the topic of a number of other research reports. KeyCorp boosted their price objective on West Pharmaceutical Services from $415.00 to $440.00 and gave […]